The Nordic Countries represent a unique opportunity when it comes to healthcare; boasting a wealth of data, some of the most advanced HealthTech, and being host to world leading biotech and pharma companies and universities. As such it is little surprise that the precision medicine revolution is creating such a buzz; disruptive technology, a strong economic setting and decades of social and health data collection are coming together to create the perfect storm for the future of healthcare in the region.
It is widely accepted that for the promise of precision medicine to become a reality we must work together; sharing data and research via a multi-disciplinary approach as well as cross border collaboration.
The event will cover a whole plethora of topics uncovering what the most pressing issues are. Hear Government talk about their vision for healthcare in the coming years, discover the latest technologies and how they are enabling a sea change in the way we treat patients and disease, learn more about the critical role of biomarkers and the latest diagnostics thinking.
Featuring 30+ expert speakers including:
- Olli Kallioniemi, Professor Director, SciLifeLab
- Finn Cilius Nielsen, Professor, Head of Genomic Medicine, Centre for Genomic Medicine, Rigshospitalet – Copenhagen University Hospital
- Dag Undlien, Professor, Head of Dept. of Medical Genetics, Oslo University Hospital
- Kim Kjoeller, EVP Global Research & Development, LEO Pharma
- Søren Brunak, Professor, NNF Center for Protein Research, University of Copenhagen
- Anders Metspalu, Full professor of Biotechnology and Director Estonian Genome Center, University of Tartu
- Prof Sue Hill OBE, Chief Science Officer, NHS England
- Mathias Uhlen PHD, Professor, KTH Royal Institute of Technology
- Morten Mau-Sørensen, Chief Physician at the Phase I unit, Department of Oncology, Rigshospitalet, Copenhagen, Denmark. President of the Danish Association for Cancer Research and a member of the Danish Health Medical Agency’s panel on experimental therapy
- Torben Falck Ørntoft, Professor, Chief Consultant, Head of Department Molecular Medicine, Aarhus University Hospital
- Morten Sogaard, Ph.D., Vice President and Head, WRD Genome Sciences & Technologies, Worldwide R&D, Pfizer, Inc.
- Paul Franks, Professor and Deputy Director of Lund University Diabetes Center in Sweden, Head of Genetic & Molecular Epidemiology Unit
**On 25 April: There will be a series of pre-conference workshops on the afternoon (15:15- 17:30) prior to the main conference. Choose your workshop which provides the opportunity to deep delve into a topic of your choice with a smaller group.
